9 research outputs found

    The effect of the CRP genetic risk score instrument of 18 SNPs associated with CRP (GRS<sub><i>GWAS</i></sub>) on somatic and neuropsychiatric outcomes after correcting for heterogeneity.

    No full text
    <p>The effect of the CRP genetic risk score instrument of 18 SNPs associated with CRP (GRS<sub><i>GWAS</i></sub>) on somatic and neuropsychiatric outcomes after correcting for heterogeneity.</p

    Genetic risk score GRS<sub><i>GWAS</i></sub> for bipolar disorder.

    No full text
    <p>The <i>x-</i>axis shows the effect size for the 18 SNPs comprising the GRS<sub><i>GWAS</i></sub> influencing levels of CRP, with corresponding standard error bars. The <i>y-</i>axis shows the log OR of the GRS<sub><i>GWAS</i></sub> SNPs for bipolar disorder (BIP) with corresponding standard error bars. The effect estimate of CRP level on disease risk is represented by the red solid line, with gradient α. The 95% CI of this α estimate is represented by the grey dashed lines. The included SNPs are shown by Arabic numbering: #1, rs2847281 (gene: <i>PTPN2</i>; chromosome: 18; basepair position: 12811593); #2, rs340029 (<i>RORA</i>; 15; 58682257); #3, rs6901250 (<i>GPRC6A</i>; 6; 117220718); #4, rs10745954 (<i>ASCL1</i>; 12; 102007224); #5, rs4705952(<i>IRF1</i>; 5; 131867517); #6, rs12037222 (<i>PABPC4</i>; 1; 39837548); #7, rs12239046 (<i>NLRP3</i>; 1; 245668218); #8, rs6734238 (<i>IL1F10</i>; 2; 113557501); #9, rs13233571 (<i>BCL7B</i>; 7; 72609167); #10, rs9987289 (<i>PPP1R3B</i>; 8; 9220768); #11, rs1260326 (<i>GCKR</i>; 2; 27584444); #12, rs4129267 (<i>IL6R</i>; 1; 152692888); #13, rs1800961 (<i>HNF4A</i>; 20; 42475778); #14, rs4420065 (<i>LEPR</i>; 1; 5934049); #15, rs10521222 (<i>SALL1</i>; 16; 49716211); #16, rs1183910 (<i>HNF1A</i>; 12; 119905190); #17, rs2794520 (<i>CRP</i>; 1; 157945440); #18, rs4420638 (<i>APOC1</i>; 19; 50114786).</p

    Genetic risk score GRS<sub><i>GWAS</i></sub> for schizophrenia.

    No full text
    <p>The <i>x-</i>axis shows the effect size for the 15 SNPs for which data were available in the PGC schizophrenia dataset comprising the GRS<sub><i>GWAS</i></sub> influencing levels of CRP, with corresponding standard error bars. The <i>y-</i>axis shows the log OR of the GRS<sub><i>GWAS</i></sub> SNPs for schizophrenia (SCZ) with corresponding standard error bars. The effect estimate of CRP level on disease risk is represented by the red solid line, with gradient α. The 95% CI of this α estimate is represented by the grey dashed lines. The included SNPs are shown by Arabic numbering: #1, rs2847281 (gene: <i>PTPN2</i>; chromosome: 18; basepair position: 12811593); #2, rs340029 (<i>RORA</i>; 15; 58682257); #3, rs6901250 (<i>GPRC6A</i>; 6; 117220718); #4, rs10745954 (<i>ASCL1</i>; 12; 102007224); #5, rs4705952 (<i>IRF1</i>; 5; 131867517); #6, rs12037222 (<i>PABPC4</i>; 1; 39837548); #7, rs12239046 (<i>NLRP3</i>; 1; 245668218); #8, rs6734238 (<i>IL1F10</i>; 2; 113557501); #9, rs13233571 (<i>BCL7B</i>; 7; 72609167); #11, rs1260326 (<i>GCKR</i>; 2; 27584444); #12, rs4129267 (<i>IL6R</i>; 1; 152692888); #13, rs1800961 (<i>HNF4A</i>; 20; 42475778); #14, rs4420065 (<i>LEPR</i>; 1; 5934049); #15, rs10521222 (<i>SALL1</i>; 16; 49716211); 12; 119905190); #17, rs2794520 (<i>CRP</i>; 1; 157945440). The three SNPs of #10, rs9987289 (<i>PPP1R3B</i>; 8; 9220768); #16, rs1183910 (<i>HNF1A</i>; and #18, rs4420638 (<i>APOC1</i>; 19; 50114786) were not present in the data of the PGC.</p

    The effect of the CRP genetic risk score instrument of 18 SNPs associated with CRP (GRS<sub><i>GWAS</i></sub>) on somatic and neuropsychiatric outcomes.

    No full text
    <p>The effect of the CRP genetic risk score instrument of 18 SNPs associated with CRP (GRS<sub><i>GWAS</i></sub>) on somatic and neuropsychiatric outcomes.</p

    The effect of the CRP genetic risk score instrument of four SNPs in CRP (GRS<sub><i>CRP</i></sub>) with somatic and neuropsychiatric outcomes.

    No full text
    <p>The effect of the CRP genetic risk score instrument of four SNPs in CRP (GRS<sub><i>CRP</i></sub>) with somatic and neuropsychiatric outcomes.</p

    Novel and previously identified BMI and WHR<sub>adjBMI</sub> loci at <i>P</i> < 5×10<sup>−8</sup> in African ancestry discovery and replication samples, and European ancestry replication samples.

    No full text
    <p>Novel and previously identified BMI and WHR<sub>adjBMI</sub> loci at <i>P</i> < 5×10<sup>−8</sup> in African ancestry discovery and replication samples, and European ancestry replication samples.</p

    Additional novel BMI and WHR<sub>adjBMI</sub> loci at <i>P</i> < 5×10<sup>−8</sup> in sex-stratified analyses of African ancestry discovery and replication samples.

    No full text
    <p>Additional novel BMI and WHR<sub>adjBMI</sub> loci at <i>P</i> < 5×10<sup>−8</sup> in sex-stratified analyses of African ancestry discovery and replication samples.</p
    corecore